Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariam Malik

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Carcinogenesis|March 6, 2012
CLIC4 is a tumor suppressor for cutaneous squamous cell cancerK Stephen Suh, Mariam Malik, Anjali Shukla, et al.
Rheumatology (Oxford, England)|August 26, 2025
Coming to a hard stop? Effect of tapered tocilizumab after weekly tocilizumab cessation for giant cell arteritis: a multicentre evaluationVanessa Quick, Stephen Sah, Shirish Dubey, et al.
Rheumatology (Oxford, England)|November 12, 2023
Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in EnglandVanessa Quick, Mahdi Abusalameh, Sajeel Ahmed, et al.
Rheumatology Advances in Practice|October 15, 2025
Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scopeStephanie F Ling, Joshua L Bennett, Vanessa J Reid, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Carcinogenesis|March 6, 2012
CLIC4 is a tumor suppressor for cutaneous squamous cell cancerK Stephen Suh, Mariam Malik, Anjali Shukla, et al.
Rheumatology (Oxford, England)|August 26, 2025
Coming to a hard stop? Effect of tapered tocilizumab after weekly tocilizumab cessation for giant cell arteritis: a multicentre evaluationVanessa Quick, Stephen Sah, Shirish Dubey, et al.
Rheumatology (Oxford, England)|November 12, 2023
Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in EnglandVanessa Quick, Mahdi Abusalameh, Sajeel Ahmed, et al.
Rheumatology Advances in Practice|October 15, 2025
Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scopeStephanie F Ling, Joshua L Bennett, Vanessa J Reid, et al.
Pageof 5